Cite

HARVARD Citation

    van Boxtel, W. et al. (2022). Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and/or metastatic salivary gland cancer. European journal of cancer. pp. 128-137. [Online]. 
  
Back to record